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score. The Z test for two proportions was used to com-
pare the KSA values with the international figures. Anal-
ysis was done using stata 10. Level of significance was set
at 5%.
Results: ‘‘Type II: type I DM ratio’’ in KSA was com-
parable to the international ratio (93.65 vs. 93.83). The
high risk factors were significantly less prevalent in
KSA in comparison to the international Figs. (17%
showed significant ST deviation P0.5 mm vs 46%,
(p = 0.005), 40% showed positive troponin vs 70%
(p < 0.0001) and, 32% showed TIMI risk score >3 in com-
parison to 62% (p < 0.0001).
The utilization of GP IIb/IIIa was 18.3% in KSA vs.
37.4% internationally (p = 0.046).
On the contrary, the utilization of clopidogril/Ticlopi-
dine was 96.8% in KSA vs. 74.7% internationally
(p < 0.0001). The percentage of early coronary angiogra-
phy was 38.9% in KSA vs. 46.1% internationally
(p = 0.292). Among patients who had early coronary angi-
ography, 34.9% had revascularization (PCI and/or CABG)
in KSA in comparison to 54.8% in the international fig-
ures (p = 0.199).
Conclusions: DM Saudi patients with ACS had sim-
ilar demographic data to the international patients. There
was a satisfactory use of evidence-based medicine in
treatment in such group.
http://dx.doi:10.1016/j.jsha.2013.03.025
Predictors and impact of in-hospital recurrent
myocardial infarction in acute coronary syndrome
patients: Findings from Gulf RACE
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K. Sulaiman, H. Alfaleh
Introduction: Little in the literature is known about
the predictors and the adverse impact of recurrent ische-
mia and infarction in patients with acute coronary syn-
drome (ACS). Accordingly; our objectives were to
determine the baseline characteristics, risk factors, and
long term outcome of patients with recurrent ischemia.
Methods: We evaluated ACS patients who were
enrolled in the second Gulf Registry of Acute Coronary
Events (Gulf RACE-2).
Results: Out of 7930 ACS patients, 172 (2.2%) devel-
oped recurrent myocardial infarction (Re-MI) during
their hospitalization. Patients with Re-MI were more
likely to be older (mean age 59.12 ± 13.5 vs. 56.8 ± 12.4;
P = 0.016), had higher rates of hyperlipidemia (41.3% vs.
32.6%; P = 0.027) and previous angina (47.7% vs. 37.9%;
P = 0.006), presented more with STEMI (72.1% vs. 43.9%;
P < 0.001), and had more Killip class 4 upon admission
(8.1% vs. 3.2%; P < 0.001) than patients without Re-MI.
Management-wise, Re-MI patients received less aspirin
(94.8% vs. 98.5%; P = 0.002), beta-blockers (59.3% vs.
74.7%; P < 0.001), and statin (87.2% vs. 94.9%; P < 0.001),
and were less frequently assessed by coronary angio-
gram (30.8% vs. 32.5%; P = 0.036). These patients had
more in-hospital complications including congestive
heart failure (44.2% vs. 12.4%) and cardiogenic shock
(25.6% vs. 5.3%) as well as higher mortality rates; both
during hospitalization (23.8% vs. 4.1%) and after a dis-
charge period of 30 days (27.3% vs. 6.8%) and 1 year
(29.1% vs. 9.3%). P < 0.001 for all comparisons.
Conclusion: Patients with recurrent infarction have a
bad prognosis in terms of in-hospital complications and
high mortality rates. High risk patients need to be moni-
tored and managed differently to prevent secondary
attacks.
http://dx.doi:10.1016/j.jsha.2013.03.026
Cardiac resynchronization therapy in children
with dilated cardiomyopathy: A case series
Abdulmohsen Al Fadley, Waleed Al Manea,
Majid Al Fayyadh, Mamdouh Al Ahmadi
Introduction: Dilated cardiomyopathy in children is
a serious disease with significant burden and poor out-
come. Ventricular desynchrony can lead to dysfunction
and dilated cardiomyopathy (DCM). For such patients,
cardiac resynchronization therapy (CRT) is a proven form
of therapy however; the role of CRT in children is not
well studied.
Objective: We aim to describe our experience with
CRT in children with poor ventricular function.
Methods: We retrospectively reviewed all pediatric
pts who underwent CRT in our institute. Data collected
include: demographics, CRT indication, pre and post
CRT ventricular assessment using echocardiogram, and
follow up clinical evaluation.
Results: Between 09/05 and 12/08, 19 pediatric pts
median age 4 years (8months to 16 years) underwent
CRT for DCM. The etiology of d DCM was chronic RV
pacing with and without congenital heart disease
(CHD) in 15 pts, myocarditis in 2, and post repair of
CHD 2. The median duration of chronic RV pacing prior
to CRT was 4yrs (1-11 yrs) and all developed DCM. One
pt had transvenous approach while all other pts had epi-
cardial leads for the left ventricular and atrium. All
devices were CRT-P. After 22 months of median follow
up (1-46 months), 13 pts improved clinically with or with-
out associated LV remolding. Theremaining 6 pts did not
respond to CRT.
Conclusion: CRT is a promising mode of therapy for
a subgroup of pediatric patients with poor ventricular
function. More studies are needed to identify those
who will benefit the most from this mode of therapy.
http://dx.doi:10.1016/j.jsha.2013.03.027
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